Author:
Duś-Ilnicka Irena,Mazur Marta,Rybińska Anna,Radwan-Oczko Małgorzata,Jurczyszyn Kamil,Paradowska-Stolarz Anna
Abstract
Abstract
Background
The COVID-19 pandemic has spread very rapidly around the world. Various regional and national lockdowns were imposed to control the spread. Meanwhile, vaccine development and population vaccination were the next steps for pandemic control. Workers in the dental field, both dentists and dental assistants, however, were close to the sources of aerosol generated during dental procedures and thus were the group of workers the most exposed to COVID-19 infection. The aim of our study was to monitor the immune response before and after the vaccine in a high-risk population, composed by dental professionals.
Methods
A clinical prospective study was carried out among dental professionals at the Academic Dental Polyclinic, Wroclaw Medical University (Wrocław, Lower Silesia region, Poland). Blood samples were collected at an interval of one year – March/April 2020, before the vaccination against COVID-19, and April 2021, after the vaccination. The analysis was performed on serum with four different methods: qualitative, semi-quantitative, and quantitative IgG count for SARS-CoV-2, and SARS-CoV-2 neutralizing antibodies.
Results
A total of 42 healthy adult volunteers participated in the study. The results showed a statistically significant difference (p < 0.05) in antibody levels before and after vaccination (1st and 2nd measurement) for each test method. The tests that were used affected the results and the test that showed the strongest relationship with the result was the Qualitative test.
Conclusions
Dental professionals are the adult working population most at risk for COVID-19. Monitoring SARS-CoV-2-status-related seropositivity can provide useful information occupational risk factors for dental professionals.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. WHO Director General’s speeches. WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020. WHO Director General’s speeches. 2020; March:4. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---18-march-2020.
2. Manzar S, Kazmi F, Bin Shahzad H, Qureshi FA, Shahbaz M, Rashid S. Estimation of the risk of COVID-19 transmission through aerosol-generating procedures. Dent Med Probl. 2022;59:351–6.
3. Duś-Ilnicka I, Szczygielska A, Kuźniarski A, Szymczak A, Pawlik-Sobecka L, Radwan-Oczko M. SARS-CoV-2 IgG Amongst Dental Workers during the COVID-19 pandemic. Int Dent J. 2022;72:353–9.
4. Nardi GM, Grassi R, Ndokaj A, Antonioni M, Jedlinski M, Rumi G et al. Maternal and neonatal oral microbiome developmental patterns and correlated factors: a systematic review—does the apple fall close to the tree? Int J Environ Res Public Health. 2021;18.
5. Mazur M, Duś-Ilnicka I, Jedliński M, Ndokaj A, Janiszewska-Olszowska J, Ardan R et al. Facial and oral manifestations following COVID-19 vaccination: a Survey-Based study and a first perspective. Int J Environ Res Public Health. 2021;18.